Endo Reports Fourth-Quarter And Full-Year 2016 Financial Results

Go back to Endo Reports Fourth-Quarter And Full-Year 2016 Financial Results

Guggenheim Reiterates Buy on Endo Int'l (ENDP) Following 4Q Beat

February 28, 2017 11:45 AM EST

Guggenheim reiterated a Buy rating and $35.00 price target on Endo International plc (NASDAQ: ENDP) following the company's 4Q earnings report. ENDP reported 4Q16 adjusted EPS of $1.77, $0.14 higher than consensus. Management gave '17 EPS guidance of $3.45-$3.75, midpoint $3.60 (consensus was $4.27).

Analyst Louise Chen... More

Endo Int'l (ENDP) Tops Q4 EPS by 14c

February 28, 2017 6:31 AM EST

Endo Int'l (NASDAQ: ENDP) reported Q4 EPS of $1.77, $0.14 better than the analyst estimate of $1.63. Revenue for the quarter came in at $1.24 billion versus the consensus estimate of $1.16 billion.

For earnings history and earnings-related data on Endo Int'l (ENDP) click here.

... More